Department of Pediatric Nephrology, Ankara University Faculty of Medicine, Ankara, Turkey.
ESPN/ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, The Netherlands.
Pediatr Nephrol. 2018 Jan;33(1):117-124. doi: 10.1007/s00467-017-3770-9. Epub 2017 Aug 4.
As outcome data for prune belly syndrome (PBS) complicated by end-stage renal disease are scarce, we analyzed characteristics and outcomes of children with PBS using the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry data.
Data were available for 88 male PBS patients aged <20 years who started renal replacement therapy (RRT) between 1990 and 2013 in 35 European countries. Patient characteristics, survival, and transplantation outcomes were compared with those of male patients requiring RRT due to congenital obstructive uropathy (COU) and renal hypoplasia or dysplasia (RHD).
Median age at onset of RRT in PBS was lower [7.0; interquartile range (IQR) 0.9-12.2 years] than in COU (9.6; IQR: 3.0-14.1 years) and RHD (9.4; IQR: 2.7-14.2 years). Unadjusted 10-year patient survival was 85% for PBS, 94% for COU, and 91% for RHD. After adjustment for country, period, and age, PBS mortality was similar to that of RHD but higher compared with COU [hazard ratio (HR) 1.96, 95% confidence interval (CI) 1.03-3.74]. Seventy-four PBS patients (84%) received a first kidney transplant after a median time on dialysis of 8.4 (IQR 0.0-21.1) months. Outcomes with respect to time on dialysis before transplantation, chance of receiving a first transplant within 2 years after commencing RRT, and death-censored, adjusted risk of graft loss were similar for all groups.
This study in the largest cohort of male patients with PBS receiving RRT to date demonstrates that outcomes are comparable with other congenital anomalies of the kidney and urinary tract, except for a slightly higher mortality risk compared with patients with COU.
由于终末期肾病合并梅干腹综合征(PBS)的预后数据有限,我们利用欧洲儿科肾脏病学会/欧洲肾脏协会-欧洲透析与移植协会(ESPN/ERA-EDTA)登记处的数据,分析了 88 例男性 PBS 患者的特征和结局,这些患者在 1990 年至 2013 年间年龄均小于 20 岁,需要在 35 个欧洲国家开始肾脏替代治疗(RRT)。比较了这些患者的生存和移植结局与因先天性尿路梗阻(COU)和肾发育不全或发育不良(RHD)而需要 RRT 的男性患者的生存和移植结局。
纳入 88 例男性 PBS 患者,年龄<20 岁,1990 年至 2013 年期间在 35 个欧洲国家开始 RRT。与因先天性尿路梗阻(COU)和肾发育不全或发育不良(RHD)而需要 RRT 的男性患者相比,比较患者特征、生存和移植结局。
PBS 患者开始 RRT 的中位年龄[7.0;四分位距(IQR)0.9-12.2 岁]低于 COU[9.6;IQR:3.0-14.1 岁]和 RHD[9.4;IQR:2.7-14.2 岁]。未经调整的 10 年患者生存率,PBS 为 85%,COU 为 94%,RHD 为 91%。校正国家、时期和年龄后,PBS 死亡率与 RHD 相似,但高于 COU[风险比(HR)1.96,95%置信区间(CI)1.03-3.74]。74 例(84%)PBS 患者在开始透析后 8.4(IQR 0.0-21.1)个月接受了首次肾移植。所有组之间,移植前透析时间、开始 RRT 后 2 年内接受首次移植的机会以及死亡风险校正的移植物丢失风险无显著差异。
这项研究纳入了迄今为止最大的男性 PBS 患者队列,这些患者接受 RRT,结果表明与其他先天性肾和尿路异常的预后相当,但与 COU 患者相比,死亡率风险略高。